Back
Recursion Pharmaceuticals Vs. Eli Lilly and Industry Stock Comparison
Sell
46
RXRX
Recursion Pharmaceuticals
Last Price:
6.81
Seasonality Move:
-13.67%
Sell
50
LLY
Eli Lilly and
Last Price:
921.81
Seasonality Move:
4.48%
Sell
46
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
- The current Recursion Pharmaceuticals [RXRX] share price is $6.93. The Score for RXRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $915.04. The Score for LLY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $6.93
The current trend is relatively stagnant and RXRX is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $915.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RXRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 51.91 | Buy |
Chaikin Money Flow: | -3306494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.29 - 7.43) | Buy |
Bollinger Bands (100): | (6.87 - 9.03) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.06 | Buy |
Relative Strength Index (14 RSI): | 50.01 | Buy |
Chaikin Money Flow: | 1774014 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (912.51 - 951.15) | Sell |
Bollinger Bands (100): | (800.64 - 929.82) | Buy |
RXRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.64 | Buy |
20-day SMA: | 6.81 | Buy |
50-day SMA: | 7.19 | Sell |
200-day SMA: | 9.05 | Sell |
8-day EMA: | 6.7 | Buy |
20-day EMA: | 6.74 | Buy |
50-day EMA: | 7.15 | Sell |
200-day EMA: | 8.29 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 916.33 | Sell |
20-day SMA: | 930.91 | Sell |
50-day SMA: | 895.06 | Buy |
200-day SMA: | 780.17 | Buy |
8-day EMA: | 916.27 | Sell |
20-day EMA: | 918.21 | Sell |
50-day EMA: | 900.51 | Buy |
200-day EMA: | 787.6 | Buy |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.17 per share, an increase this year of $0.09 per share, and a decrease next year of $0.16 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $4.62 per share, an increase next quarter of $1.15 per share, an increase this year of $10.06 per share, and an increase next year of $6.23 per share.
Recursion Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |